Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar;17(3):28.
doi: 10.1007/s11910-017-0732-3.

Dietary Interventions and Multiple Sclerosis

Affiliations
Review

Dietary Interventions and Multiple Sclerosis

Ghadah Altowaijri et al. Curr Neurol Neurosci Rep. 2017 Mar.

Erratum in

Abstract

Multiple Sclerosis (MS) is a chronic, disabling neurologic disease that has its onset in young adulthood. While the knowledge about underlying pathogenesis of MS has improved significantly over the last few decades, the exact cause still eludes us. Despite the availability of several United States Food and Drug Administration-approved disease-modifying therapies (DMT) for MS in the last two decades, the disease remains disabling for many. DMT use is limited by its partial effectiveness, significant side effects in many cases, and high cost that leads people with MS (PwMS) to look for alternative management options. Dietary intervention as a possible mode to help MS seems very appealing to PwMS; however, scientific data supporting this notion remains sparse. New information on the role of various non-MS health factors, especially vascular disease risk factors such as hypertension, hyperlipidemia, salt intake, and obesity, that may play a role in MS pathogenesis appears very intriguing as it may partly explain the heterogeneity seen in MS activity and disability. This review will highlight the emerging information on various dietary approaches that may affect MS and their possible underlying mechanism.

Keywords: Diet; MS pathogenesis; Multiple sclerosis; Nutrition; Obesity; Vascular disease risk factors.

PubMed Disclaimer

References

    1. Prostaglandins Leukot Essent Fatty Acids. 2005 Nov;73(5):397-404 - PubMed
    1. Mult Scler. 2015 Oct;21(12):1485-95 - PubMed
    1. Nutrition. 1991 Sep-Oct;7(5):368-76 - PubMed
    1. Neurol Clin. 2011 May;29(2):233-55 - PubMed
    1. Cochrane Database Syst Rev. 2012 Dec 12;12:CD004192 - PubMed

LinkOut - more resources